Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan-Dec:21:15330338221118211.
doi: 10.1177/15330338221118211.

Feasibility of ERAS in Patients With Gastric Cancer Complicated by Diabetes Mellitus

Affiliations
Review

Feasibility of ERAS in Patients With Gastric Cancer Complicated by Diabetes Mellitus

Ying Wang et al. Technol Cancer Res Treat. 2022 Jan-Dec.

Abstract

Enhanced Recovery After Surgery (ERAS) is the integration of multiple perioperative evidence-based medical practices into a single pathway aimed at eliminating surgical liabilities and improving treatment accuracy to enhance patients' postoperative outcomes. The ERAS Society has been developing guidelines that are widely applicable in the surgical field. ERAS pathways in selective and noncomplicated cases are extensively practiced. However, the ERAS literature excludes patients with comorbidities, such as gastric cancer complicated with diabetes mellitus (DM). Current ERAS guidelines exclude patients with DM in enhanced recovery programs because of insufficient evidence-based medicine on the molecular physiology of the patients in response to surgical insult. Therefore, it is important to implement accelerated rehabilitation surgery for patients with gastric cancer and DM. This review discusses the feasibility and necessity of applying ERAS guidelines to patients with gastric cancer complicated by DM. In addition, we documented the need to lay a logical foundation for enhanced recovery after surgery in patients with gastric cancer complicated by DM.

Keywords: enhanced recovery after surgery; feasibility; gastric cancer complicated with diabetes mellitus; logic foundation; necessity.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Similar articles

References

    1. Seeras K, Sankararaman S, Lopez PP. Sleeve Gastrectomy. StatPearlsPearls Publishing.Copyright © 2021. StatPearls Publishing LLC; 2021. - PubMed
    1. Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth. 1997;78(5):606-617. doi: 10.1093/bja/78.5.606 - DOI - PubMed
    1. Kotagal M, Symons RG, Hirsch IB, et al. Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg. 2015;261(1):97-103. doi: 10.1097/SLA.0000000000000688 - DOI - PMC - PubMed
    1. Miao ZF, Xu H, Xu YY, et al. Diabetes mellitus and the risk of gastric cancer: a meta-analysis of cohort studies. Oncotarget. 2017;8(27):44881-44892. doi: 10.18632/oncotarget.16487 - DOI - PMC - PubMed
    1. Ge LN, Wang L, Wang F. Effectiveness and safety of preoperative oral carbohydrates in enhanced recovery after surgery protocols for patients with diabetes mellitus: a systematic review. BioMed Res Int. 2020;2020:5623596. doi: 10.1155/2020/5623596 - DOI - PMC - PubMed

Publication types